Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.37 and traded as low as $0.26. Northwest Biotherapeutics shares last traded at $0.30, with a volume of 4,037,524 shares traded.
Northwest Biotherapeutics Price Performance
The firm has a 50 day simple moving average of $0.30 and a 200-day simple moving average of $0.37. The company has a market cap of $395.24 million, a price-to-earnings ratio of -3.81 and a beta of -0.55.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last posted its earnings results on Friday, August 9th. The biotechnology company reported ($0.02) EPS for the quarter. The business had revenue of $0.51 million for the quarter.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
See Also
- Five stocks we like better than Northwest Biotherapeutics
- Ride Out The Recession With These Dividend Kings
- California Resources Stock Could Be a Huge Long-Term Winner
- Stock Analyst Ratings and Canadian Analyst Ratings
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- What is a buyback in stocks? A comprehensive guide for investors
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
